Company Overview
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Company Information
- CEO
- James E. Davis
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 55000
Contact Information
- Address
- 500 Plaza Drive
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 20.15B market capitalization
- Trading Volume: 919.11K shares traded today
- Price Range: 52-week range of $146.17 - $185.60
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 20.15B, the company represents a significant player in its market. The stock is currently trading at $180.23 with a negativedaily change of 1.90%.
The company's 55000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 21.58, beta of 0.46, and 52-week price range from $146.17 to $185.60when evaluating investment opportunities.
Why Invest in Quest Diagnostics Incorporated?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under James E. Davis
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.